Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective and Randomized Study of Efficacy and Safety of Transdermal Oxybutynin Versus Oral Oxybutynin in The Management of Children With Overactive Bladder

NCT07081906 is registered in ClinicalTrials.gov with Dr. Lutfi Kirdar Kartal Training and Research Hospital as lead sponsor.

NCT NCT07081906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07081906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective and Randomized Study of Efficacy and Safety of Transdermal Oxybutynin Versus Oral Oxybutynin in The Management of Children With Overactive Bladder
Lead sponsor
Dr. Lutfi Kirdar Kartal Training and Research Hospital
Phase
Not applicable
Overall status
Completed
Start date
February 15, 2019
Completion date
May 1, 2020
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticholinergic side effects, children and adolescents, boys and girls, drug delivery systems, overactive bladder (oab)